These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Clozapine-induced tardive dyskinesia: a case report. Ertugrul A; Demir B Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369 [TBL] [Abstract][Full Text] [Related]
27. [Improvement of tardive dyskinesia with high doses of propranolol]. Moreira MJ; Karniol IG Rev Paul Med; 1979; 93(3-4):76-8. PubMed ID: 40299 [No Abstract] [Full Text] [Related]
28. Neuroleptic medication facilitates the natural occurrence of tardive dyskinesia. A critical review. Driesens F Acta Psychiatr Belg; 1988; 88(3):195-205. PubMed ID: 2906780 [TBL] [Abstract][Full Text] [Related]
29. Diazepam in the treatment of extrapyramidal symptoms: a case report. Director KL; Muniz CE J Clin Psychiatry; 1982 Apr; 43(4):160-1. PubMed ID: 6121790 [TBL] [Abstract][Full Text] [Related]
30. A prospective study of tardive dyskinesia development: preliminary results. Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353 [TBL] [Abstract][Full Text] [Related]
31. Parallels between neuroleptic effects and lethargic encephalitis: the production of dyskinesias and cognitive disorders. Breggin PR Brain Cogn; 1993 Sep; 23(1):8-27. PubMed ID: 8105824 [TBL] [Abstract][Full Text] [Related]
32. Comparison of severe and mild tardive dyskinesia: implications for etiology. Gardos G; Cole JO; Schniebolk S; Salomon M J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550 [TBL] [Abstract][Full Text] [Related]
33. Risperidone and tardive dyskinesia in organic psychosis. Fischer P; Tauscher J; Küfferle B Pharmacopsychiatry; 1998 Mar; 31(2):70-1. PubMed ID: 9562212 [No Abstract] [Full Text] [Related]
34. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. Normann C; Brandt C; Berger M; Walden J Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353 [TBL] [Abstract][Full Text] [Related]
35. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients. Hansen TE; Brown WL; Weigel RM; Casey DE J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762 [TBL] [Abstract][Full Text] [Related]
38. The role of melatonin in the antipsychotic and motor-side effects of neuroleptics: a hypothesis. Sandyk R; Kay SR; Gillman MA Int J Neurosci; 1992; 64(1-4):203-7. PubMed ID: 1364141 [TBL] [Abstract][Full Text] [Related]
39. An unusual presentation of tardive dyskinesia with prominent involvement of the pectoral musculature. Gupta S; Egan MF; Hyde TM Biol Psychiatry; 1993 Feb; 33(4):291-2. PubMed ID: 8097115 [No Abstract] [Full Text] [Related]
40. [Computer tomographic studies of patients with neuroleptic-induced disorders of extrapyramidal motor activity]. Stuckstedte H; Bartels M; Naumann D; Schied HW; Schroth G Nervenarzt; 1984 Sep; 55(9):483-7. PubMed ID: 6150448 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]